vs
NovoCure Ltd（NVCR）与Rapid7, Inc.（RPD）财务数据对比。点击上方公司名可切换其他公司
Rapid7, Inc.的季度营收约是NovoCure Ltd的1.2倍（$217.4M vs $174.1M），Rapid7, Inc.净利率更高（1.4% vs -40.9%，领先42.3%），NovoCure Ltd同比增速更快（12.3% vs 0.5%），过去两年NovoCure Ltd的营收复合增速更高（7.6% vs 3.0%）
NovoCure Ltd是一家全球肿瘤医疗企业，专注研发肿瘤治疗电场（TTFields）技术，推出可穿戴非侵入式癌症治疗设备，已获批用于胶质母细胞瘤、恶性胸膜间皮瘤、非小细胞肺癌等多个癌种，业务覆盖北美、欧洲及亚太地区。
Rapid7是全球领先的网络安全企业，提供漏洞管理、威胁检测与响应、云安全、安全分析等全系列安全解决方案，服务全球科技、医疗、金融、制造等行业的各类规模企业及公共部门客户，助力客户高效识别、应对和缓解网络安全风险。
NVCR vs RPD — 直观对比
营收规模更大
RPD
是对方的1.2倍
$174.1M
营收增速更快
NVCR
高出11.8%
0.5%
净利率更高
RPD
高出42.3%
-40.9%
两年增速更快
NVCR
近两年复合增速
3.0%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $174.1M | $217.4M |
| 净利润 | $-71.1M | $3.1M |
| 毛利率 | 77.6% | 68.9% |
| 营业利润率 | — | 1.0% |
| 净利率 | -40.9% | 1.4% |
| 营收同比 | 12.3% | 0.5% |
| 净利润同比 | -107.3% | 44.1% |
| 每股收益（稀释后） | — | $0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NVCRRPD
| Q1 26 | $174.1M | — | ||
| Q4 25 | $174.3M | $217.4M | ||
| Q3 25 | $167.2M | $218.0M | ||
| Q2 25 | $158.8M | $214.2M | ||
| Q1 25 | $155.0M | $210.3M | ||
| Q4 24 | $161.3M | $216.3M | ||
| Q3 24 | $155.1M | $214.7M | ||
| Q2 24 | $150.4M | $208.0M |
净利润NVCRRPD
| Q1 26 | $-71.1M | — | ||
| Q4 25 | $-24.5M | $3.1M | ||
| Q3 25 | $-37.3M | $9.8M | ||
| Q2 25 | $-40.1M | $8.3M | ||
| Q1 25 | $-34.3M | $2.1M | ||
| Q4 24 | $-65.9M | $2.2M | ||
| Q3 24 | $-30.6M | $15.4M | ||
| Q2 24 | $-33.4M | $6.5M |
毛利率NVCRRPD
| Q1 26 | 77.6% | — | ||
| Q4 25 | 75.8% | 68.9% | ||
| Q3 25 | 73.2% | 70.2% | ||
| Q2 25 | 73.9% | 70.6% | ||
| Q1 25 | 75.1% | 71.7% | ||
| Q4 24 | 79.2% | 69.5% | ||
| Q3 24 | 77.2% | 70.6% | ||
| Q2 24 | 77.0% | 70.7% |
营业利润率NVCRRPD
| Q1 26 | — | — | ||
| Q4 25 | -23.2% | 1.0% | ||
| Q3 25 | -21.5% | 2.7% | ||
| Q2 25 | -24.9% | 1.6% | ||
| Q1 25 | -24.4% | -0.0% | ||
| Q4 24 | -39.3% | 3.4% | ||
| Q3 24 | -20.7% | 6.0% | ||
| Q2 24 | -22.3% | 2.5% |
净利率NVCRRPD
| Q1 26 | -40.9% | — | ||
| Q4 25 | -14.1% | 1.4% | ||
| Q3 25 | -22.3% | 4.5% | ||
| Q2 25 | -25.3% | 3.9% | ||
| Q1 25 | -22.1% | 1.0% | ||
| Q4 24 | -40.9% | 1.0% | ||
| Q3 24 | -19.7% | 7.2% | ||
| Q2 24 | -22.2% | 3.1% |
每股收益（稀释后）NVCRRPD
| Q1 26 | — | — | ||
| Q4 25 | $-0.22 | $0.05 | ||
| Q3 25 | $-0.33 | $0.15 | ||
| Q2 25 | $-0.36 | $0.13 | ||
| Q1 25 | $-0.31 | $0.03 | ||
| Q4 24 | $-0.61 | $0.08 | ||
| Q3 24 | $-0.28 | $0.21 | ||
| Q2 24 | $-0.31 | $0.09 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $432.0M | $474.7M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $330.7M | $154.7M |
| 总资产 | $787.9M | $1.7B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资NVCRRPD
| Q1 26 | $432.0M | — | ||
| Q4 25 | $93.5M | $474.7M | ||
| Q3 25 | $342.1M | $407.1M | ||
| Q2 25 | $149.6M | $511.7M | ||
| Q1 25 | $127.3M | $493.5M | ||
| Q4 24 | $163.8M | $521.7M | ||
| Q3 24 | $185.4M | $443.7M | ||
| Q2 24 | $164.8M | $442.6M |
股东权益NVCRRPD
| Q1 26 | $330.7M | — | ||
| Q4 25 | $340.5M | $154.7M | ||
| Q3 25 | $341.3M | $127.2M | ||
| Q2 25 | $349.4M | $90.4M | ||
| Q1 25 | $362.0M | $52.7M | ||
| Q4 24 | $360.2M | $17.7M | ||
| Q3 24 | $360.8M | $-5.1M | ||
| Q2 24 | $361.8M | $-52.6M |
总资产NVCRRPD
| Q1 26 | $787.9M | — | ||
| Q4 25 | $804.3M | $1.7B | ||
| Q3 25 | $1.4B | $1.7B | ||
| Q2 25 | $1.2B | $1.6B | ||
| Q1 25 | $1.2B | $1.6B | ||
| Q4 24 | $1.2B | $1.7B | ||
| Q3 24 | $1.2B | $1.6B | ||
| Q2 24 | $1.2B | $1.5B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $37.6M |
| 自由现金流经营现金流 - 资本支出 | — | $36.4M |
| 自由现金流率自由现金流/营收 | — | 16.8% |
| 资本支出强度资本支出/营收 | — | 0.5% |
| 现金转化率经营现金流/净利润 | — | 12.01× |
| 过去12个月自由现金流最近4个季度 | — | $146.2M |
8季度趋势，按日历期对齐
经营现金流NVCRRPD
| Q1 26 | — | — | ||
| Q4 25 | $-18.0M | $37.6M | ||
| Q3 25 | $20.6M | $39.0M | ||
| Q2 25 | $-15.9M | $47.5M | ||
| Q1 25 | $-35.7M | $29.8M | ||
| Q4 24 | $-3.5M | $63.8M | ||
| Q3 24 | $10.4M | $44.0M | ||
| Q2 24 | $-1.7M | $32.9M |
自由现金流NVCRRPD
| Q1 26 | — | — | ||
| Q4 25 | $-22.9M | $36.4M | ||
| Q3 25 | $14.9M | $34.8M | ||
| Q2 25 | $-21.4M | $46.6M | ||
| Q1 25 | $-46.3M | $28.4M | ||
| Q4 24 | $-12.4M | $62.6M | ||
| Q3 24 | $-307.0K | $42.6M | ||
| Q2 24 | $-13.2M | $32.6M |
自由现金流率NVCRRPD
| Q1 26 | — | — | ||
| Q4 25 | -13.1% | 16.8% | ||
| Q3 25 | 8.9% | 16.0% | ||
| Q2 25 | -13.5% | 21.8% | ||
| Q1 25 | -29.9% | 13.5% | ||
| Q4 24 | -7.7% | 28.9% | ||
| Q3 24 | -0.2% | 19.9% | ||
| Q2 24 | -8.8% | 15.7% |
资本支出强度NVCRRPD
| Q1 26 | — | — | ||
| Q4 25 | 2.8% | 0.5% | ||
| Q3 25 | 3.4% | 1.9% | ||
| Q2 25 | 3.5% | 0.4% | ||
| Q1 25 | 6.8% | 0.6% | ||
| Q4 24 | 5.5% | 0.5% | ||
| Q3 24 | 6.9% | 0.6% | ||
| Q2 24 | 7.6% | 0.1% |
现金转化率NVCRRPD
| Q1 26 | — | — | ||
| Q4 25 | — | 12.01× | ||
| Q3 25 | — | 3.97× | ||
| Q2 25 | — | 5.70× | ||
| Q1 25 | — | 14.14× | ||
| Q4 24 | — | 29.36× | ||
| Q3 24 | — | 2.85× | ||
| Q2 24 | — | 5.03× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
NVCR
暂无分部数据
RPD
| Products | $209.1M | 96% |
| Services | $8.2M | 4% |
